What is LOPJLB’s current signal on OGEN?

LOPJLB’s latest quantitative signal on Oragenics, Inc. (OGEN) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is OGEN in?

Oragenics, Inc. (OGEN) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Oragenics, Inc. (OGEN) do?

Oragenics, Inc. (OGEN) is a U.S.-based biotechnology firm primarily focused on creating treatments for infectious diseases. Among its pipeline assets are two vaccine candidates designed to combat the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2): NT-CoV2-1, an intranasal formulation, and Terra CoV-2, an intramuscular option. Beyond its infectious disease focus, Oragenics also…

Oragenics, Inc. (OGEN)

COMPARE

Healthcare · Biotechnology · AMEX · US

$0.45+0.00%Close

SELLCRISIS · day 4

[SCORES & PROFILE]

FUND: 5
VALUE: 17
GROWTH: 39
GARP: 0
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-86.5%

REV YoY-

ROE-144.2%

EPS YoY-

ROA-183.6%

GROSS

NET

[VALUATION]

P/E TTM-0.12

P/E FWD-

SECTOR PE20.48

INDUSTRY PE13.99

P/B0.54

P/FCF-

EV/EBITDA0.26

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E-

ALTMAN Z-

CURR RATIO3.01

ND/EBITDA-

BETA1.26

FAQ

What is LOPJLB’s current signal on OGEN?: LOPJLB’s latest quantitative signal on Oragenics, Inc. (OGEN) is SELL in a CRISIS regime. Signals are updated daily.
What market regime is OGEN in?: Oragenics, Inc. (OGEN) is currently classified in the CRISIS HMM market regime on LOPJLB.
What does Oragenics, Inc. (OGEN) do?: Oragenics, Inc. (OGEN) is a U.S.-based biotechnology firm primarily focused on creating treatments for infectious diseases. Among its pipeline assets are two vaccine candidates designed to combat the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2): NT-CoV2-1, an intranasal formulation, and Terra CoV-2, an intramuscular option. Beyond its infectious disease focus, Oragenics also…

Oragenics, Inc. (OGEN)

Key stats

Prediction markets

FUNDAMENTALS

Company news

FAQ